Neurologic, psychological, and aggressive disturbances with sildenafil

Annals of Pharmacotherapy

Volumn 36, Issue 7-8, 2002, Pages 1129-1134

  Milman, Harry A ^a   Arnold, Suzanne B ^a   Rivera Miranda, Giselle ^a   Le Duff, Michel ^a  

^a ToxNetworkcom   (United States)

Author keywords

Erectile dysfunction; Sildenafil

Indexed keywords

CYCLIC AMP PHOSPHODIESTERASE; CYCLIC AMP PHOSPHODIESTERASE 5; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; UNCLASSIFIED DRUG; PIPERAZINE DERIVATIVE;

ADULT; AFFECTIVE NEUROSIS; AGED; AGGRESSION; AMNESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; CONFUSION; DELUSION; DEPERSONALIZATION; DISEASE ASSOCIATION; DISEASE COURSE; DREAMING; DRUG FORMULATION; DRUG SAFETY; EMOTION; ENZYME INHIBITION; ERECTILE DYSFUNCTION; FOOD AND DRUG ADMINISTRATION; HALLUCINATION; HOMICIDE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; INFORMATION PROCESSING; LIBIDO; MALE; MANIA; MENTAL DISEASE; MOUSE; NEUROLOGICAL COMPLICATION; NONHUMAN; PARANOIA; PERSONALITY DISORDER; PRIORITY JOURNAL; RAPE; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; SUICIDAL BEHAVIOR; UNCONSCIOUSNESS; ANIMAL; BRAIN; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; REVIEW; SOCIOPATHY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGGRESSION; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; MALE; MICE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SEXUAL BEHAVIOR, ANIMAL; SOCIAL BEHAVIOR DISORDERS;

EID: 0036020153     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A402     Document Type: Article

References (54)

1. Oral sildenafil in the treatment of erectile dysfunction
2. Efficacy of sildenafil citrate (Viagra) is not affected by aetiology of erectile dysfunction
3. Viagra: What every physician should know
4. Sildenafil (Viagra) and ophthalmology
5. Sildenafil citrate (Viagra): Overall safety profile in 18 double-blind controlled, clinical trials
6. Sildenafil citrate (Viagra) in the treatment of erectile dysfunction: A 12-week, flexible-dose study to assess efficacy and safety
7. A 36-week, open label, non-comparative study to assess the long-term safety of sildenafil citrate (Viagra) in patients with erectile dysfunction
8. Sildenafil citrate (Viagra) in the treatment of erectile dysfunction: Analysis of two flexible dose-escalation studies
9. Sildenafil citrate (Viagra): Analysis of preferred doses in a European, six-month, double-blind, placebo-controlled, flexible dose-escalation study in patients with erectile dysfunction
10. Sildenafil citrate (Viagra): An oral treatment for erectile function with activity for up to four hours' duration
11. Sildenafil citrate
12. Psychosocial side effects of sildenafil therapy for erectile dysfunction
13. Unusual case report: Nonpharmacologic effects of sildenafil
14. Sildenafil citrate-associated priapism
15. Viagra killer gets 18 years
16. Sympathetic activation by sildenafil
17. Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: A study with event-related brain potentials
18. Inhibition of neuronal nitric oxide synthase increases aggressive behavior in mice
19. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase
20. Nitric oxide synthase: Role as a transmitter/mediator in the brain and endocrine system
21. Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase
22. 2+ independent nitric oxide synthases
23. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain
24. Nitric-oxide-induced cGMP synthesis in cholinergic neurons in the rat brain
25. Nitric oxide signaling in the central nervous system
26. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
27. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells
28. The nitric oxide-cyclic GMP signalling pathway in rat brain
29. Intercellular action of nitric oxide increases cGMP in cerebellar Purkinje cells
30. Nitric oxide may act as a messenger between dorsal root ganglion neurones and their satellite cells
31. Nitric oxide: A brake for bad behavior
32. Molecular basis of aggression
33. Aggressive behavior in male mice lacking the gene for neuronal nitric oxide synthase requires testosterone
34. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase
35. Cyclic GMP synthesis and function
36. Influence of cyclic nucleotides on defensive, offensive and predatory aggression in rodents
37. Cyclic nucleotides and aggressive behavior
38. Retinal side-effects of sildenafil
39. Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat
40. Should patients be given an initial low test dose of sildenafil?
41. Sildenafil (Viagra) is used as a recreational drug in England
42. A study of the German outbreak of phocomelia: The thalidomide syndrome
43. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina
44. Adverse cardiovascular events associated with the use of Viagra
45. Some men who take Viagra die - Why?
46. How dangerous is Viagra?
47. Acute renal failure in a young man, 9 days after a 5-h persisting erection following Viagra: Is there a causal relationship?